Rybelsus (oral semaglutide) is the only FDA-approved oral GLP-1 medication. It delivers semaglutide through absorption enhancers that help the peptide cross the intestinal barrier. However, Rybelsus is only approved for type 2 diabetes, not weight loss. For weight management, injectable forms remain the only option. Oral semaglutide requires taking on an empty stomach with 4 ounces of plain water, then waiting 30 minutes before eating, drinking, or taking other medications. This complex administration protocol and lower bioavailability make the injectable forms more popular for weight management despite needle aversion.
Find a qualified GLP-1 provider
Compare pricing, clinical oversight, and patient reviews across verified telehealth programs and local clinics.
Compare Providers →Still have questions?
A qualified GLP-1 provider can give you personalized answers based on your medical history and goals.
Get answers to your GLP-1 questions
Weekly updates with the latest research, pricing changes, and expert guidance — delivered to your inbox.
No spam. Unsubscribe anytime.
Ready to start your GLP-1 journey?
Compare verified providers on pricing, medication sourcing, clinical oversight, and patient reviews — all in one place.